Intravenous streptokinase and percutaneous transluminal coronary angioplasty in acute myocardial infarction.
Intravenous streptokinase already has been demonstrated safe and beneficial in acute myocardial infarction. The adjunction of early angiography seems to be safe, providing the possibility of full revascularization in a larger number of patients with a high rate of primary success. The improvement of global ventricular function, the reduction of mortality, post infarction angina and reocclusion have to be confirmed by longer follow-up.
D000800:Angioplasty, Balloon; D002986:Clinical Trials as Topic; D006801:Humans; D007262:Infusions, Intravenous; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D011897:Random Allocation; D013300:Streptokinase / Q000627:therapeutic use*; D013997:Time Factors
D013300:Streptokinase